Does anyone know when the $36.9m in TD investments matured? 183 days since the CR would suggests to me that this would simply be held as additional cash now, or a portion rolled over and reinvested, but nothing in the accounts in this regard. What are investors' thoughts on the cash levels to see us through this year's R&D and admin expenditure? Anyone expect cost increases of any significance in ramping up CANVAS clinical trials during 2012? $4.1m Saxony grant for European trials nice to have tucked away and ready.
half yearly report, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $454.5M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.8¢ | 31.0¢ | $355.4K | 1.129M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 54 | 836231 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 318762 | 30 |
View Market Depth
| Last trade - 12.57pm 08/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |